October 2002 – The CenterWatch Monthly : Volume 9, Issue 10, October 2002
Rethinking the Role of AHC Clinical Trial Offices
Academic health centers (AHCs) that led the charge to form centralized clinical trial offices are now rethinking their structure and purpose. Although some institutions have continued expanding their service offerings, others are decentralizing and disbanding the function.
Phase IV Market Steams Ahead
Phase IV studies are the fastest growing segment of clinical spending, reaching nearly $4 billion in 2002. This sweet spot in the market is being actively pursued by CROs and offers unique opportunities for experienced, community-based clinical investigators.
CentreStage Europe: A Look at Sweden's Karolinska Institute
Although best know abroad as the home of the committee responsible for choosing Nobel Prize winners, the Karolinska Institute is also the powerhouse of Sweden's biomedical research efforts.
Eye On: Type 2 Diabetes
CenterWatch has identified a pipeline of 44 drugs in development for type 2 diabetes, including different insulin formulations, lipid-lowering agents, hormone analogs and hypoglycemic.
- Month in Review
- In the Pipeline
- Opportunities Underway